WilliamRJarnaginMD
General Surgery • New York, NYSurgical Oncology (Other than Breast)
Chief, Hepatopancreatobiliary Service at MSK Benno C. Schmidt Chair in Surgical Oncology
Overview of Dr. Jarnagin
Dr. William Jarnagin is a general surgeon in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan-Kettering Cancer Center and Memorial Sloan-Kettering Cancer Center. He received his medical degree from Rush Medical College and has been in practice 29 years. He specializes in surgical oncology (other than breast) and is experienced in cholangiocarcinoma, surgical oncology (non-breast), and hepatopancreatobiliary surgery.
Office
Memorial Sloan Kettering Cancer Center New York
1275 York Avenue
New York, NY 10021- Is this information wrong?
Education & Training
University of California (San Francisco)Residency, Surgery, 1988 - 1996
Rush Medical College of Rush University Medical CenterClass of 1988
Certifications & Licensure
FL State Medical License 2021 - Present
CA State Medical License 1989 - Present
NY State Medical License 1996 - 2025- American Board of Surgery Surgery
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- Top Doctors: New York Metro Area Castle Connolly, 2009-2014
- New York Magazine: Top Doctors Castle Connolly, 2009, 2011-2014
- Join now to see all
Clinical Trials
- Acute Normovolemic Hemodilution Versus Standard Intraoperative Management in Patients Having Hepatic Resection and Pancreaticoduodenectomy Start of enrollment: 2004 Mar 01
- Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by Surgery Start of enrollment: 2007 May 01
- A Phase II Study of Continuous Hepatic Arterial Infusion With Floxuridine (FUDR) and Dexamethasone (DEX) in Patients With Unresectable Primary Hepatic Malignancy Start of enrollment: 2003 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsHigher Postoperative Mortality and Inferior Survival After Right-Sided Liver Resection for Perihilar Cholangiocarcinoma: Left-Sided Resection is Preferred When Possible.Pim B Olthof, Joris I Erdmann, Ruslan Alikhanov, Ramón Charco, Alfredo Guglielmi, Jeroen Hagendoorn, Abdul Hakeem, Frederik J H Hoogwater, William R Jarnagin, Geert Ka...> ;Annals of Surgical Oncology. 2024 Mar 12
- Comparison study of intraoperative surface acquisition methods on registration accuracy for soft-tissue surgical navigation.Xiang, B., Heiselman, J., Richey, W., D'Angelica, M., Servin, F., Pereira, K., Miga, M., Wei, A., Kingham, T., Geevarghese, S., Jarnagin, W.> ;Journal of Medical Imaging. 2024 Mar 1
- Concordance in Oncogenic Alterations Between the Primary Tumor and Advanced Disease: Insights Into the Heterogeneity of Intrahepatic Cholangiocarcinoma.Harding, J., Sarah M McIntyre, William A Preston, Henry Walch, Jeremy Sharib, Ritika Kundra, Carlie Sigel, Michael E Lidsky, Peter J Allen, Michael A Morse, Wei Chen, ...> ;JCO Precision Oncology. 2024 Feb 1
- Join now to see all
Journal Articles
- Questioning Why More Patients with Colorectal Liver Metastases Are Not Referred for MetastasectomyAlice C Wei, William R Jarnagin, JAMA Surgery
- Laparoscopic Liver Resection Difficulty Score—a Validation StudyRyan P Merkow, William R Jarnagin, Journal of gastrointestinal surgery
- Quantitative Imaging Features of Pretreatment CT Predict Volumetric Response to Chemotherapy in Patients with Colorectal Liver MetastasesAndrea Cercek, William R Jarnagin, Jinru Shia, Peter J Allen, Kenneth P Seastedt, Nancy E Kemeny, Ronald P DeMatteo, Vinod P Balachandran, T Peter Kingham, European Radiology
Authored Content
- Questioning Why More Patients with Colorectal Liver Metastases Are Not Referred for MetastasectomyJuly 2020
Press Mentions
Reprogrammed Cells Attack and Tame Deadly Cancer in One WomanJune 1st, 2022- Developing a Different Type of Liquid Biopsy to Detect CancerAugust 17th, 2020
$2.3 Million NIH Grant Allows Collaborators Focus on Advancing Liver Cancer Surgical CareOctober 10th, 2019- Join now to see all
Grant Support
- Clinical Translation Of Deformation Compensation For Image-Guided Liver SurgeryNational Cancer Institute2011
- Hepatic Arterial Flouridine And IV Bevacizumab For Primary Hepatic MalignancyNational Cancer Institute2007–2008
Professional Memberships
- Member
- Member
Hospital Affiliations
Memorial Sloan Kettering Cancer CenterNew York, New York- Memorial Hospital for Cancer and allied DiseasesBasking Ridge, New Jersey
Insurance Accepted
- BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
GHI PPO
Great West PPOHumana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
